Frey discussed the role of various cosmeceuticals and ingredients in benefitting the skin health of patients, as well as insights into pairing OTC products with Rx.
Steve Feldman, MD, PhD, is part of an atopic dermatitis panel and focuses on strategies to hold pediatric patients and their parents accountable to treatment methods.
Scurto presented integrative medicine pearls at the 2024 Diversity in Dermatology meeting.
Kamran H. Imam, MD, hopes to unlock insights into the atopic disease burden among Native American populations.
An alarming amount of COVID-19 disinformation is prevalent even from physicians.
Lifestyle behaviors, such as body mass index and smoking, were shown to have a stronger association with psoriasis, regardless of genetic risk.
In part 4 of this Frontline Forum series, John M. Strasswimmer, MD, PhD; Andrew H. Weinstein, MD; Neal Bhatia, MD; Laura Ferris, MD; and Aaron S. Farberg, MD, discuss solutions for managing and treating patients with basal cell carcinoma.
Dr Linda Stein-Gold and Dr Michael Cameron assess the safety and tolerability of topical ruxolitinib cream, offering guidance on counseling patients about the black box warning. They also address the perception of limited treatment access and strategies for overcoming this barrier.
A patient returns to your clinic seeking systemic therapy for her AD while postpartum and breastfeeding. Test your knowledge on injectables.
Shawn Kwatra, MD, shares positive updates on phase 2 oral povorcitinib for prurigo nodularis at AAD 2024.
Doctors cite more support staff, reduced patient panels among solutions.
Dermatology Times® invites medical professionals in the dermatology community to speak out on the vital issues facing the specialty.
AI’s ability to quickly process and interpret large quantities of health data is a valuable tool for physicians.
In most kidney transplant recipients with advanced skin cancer, 2 checkpoint inhibitors are needed to boost the immune system, according to a new study.
Dermatologists Jeanine Downie, DiAnne Davis, and Hope Mitchell reveal the La Roche-Posay products they recommend to patients with dry skin, eczema, and more, at the flagship store in France.
Daniel Siegel, MD, shared strategies to manage surgery challenges, especially bleeding, to ensure a smooth experience for patients.
Survey responses revealed the rates and times at which patients switched from oral to biologic therapies.
Findings from a retrospective cohort study found that immune checkpoint inhibitors induced promising responses in the first- and second-line treatment of head and neck squamous cell carcinoma.
Expert insights on the latest issues in wounds as well as HS resources are shared at the annual meeting.
Jeffrey Yager, MD, discusses the new SY Aesthetics campus that will integrate traditional and Chinese healing.
In part 4 of this Frontline Forum series, John M. Strasswimmer, MD, PhD; Andrew H. Weinstein, MD; Neal Bhatia, MD; Laura Ferris, MD; and Aaron S. Farberg, MD, discuss solutions for managing and treating patients with basal cell carcinoma.
In this study, researchers treated 37 basal cell carcinoma (BCC) lesions from 30 patients, with follow-ups at 5 time points after baseline examination.
Test your knowledge to see if your patients would consider you an efficient texter.
Peter Lio, MD, reflects on current unmet needs in atopic dermatitis and suggests directions for future research and development.
Experts discuss the treatment landscape of generalized pustular psoriasis as well as review difficult cases of GPP.
Jerry Brewer, MD, MS, shared pearls on reasons to avoid or discontinue Mohs surgery and keeping calm with stressed, vulnerable patients.